These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4126382)

  • 1. Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.
    Livingston RB; Bodey GP; Gottlieb JA; Frei E
    Cancer Chemother Rep; 1973 Apr; 57(2):219-24. PubMed ID: 4126382
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleomycin in the treatment of metastatic cancer.
    Depierre A
    Prog Biochem Pharmacol; 1976; 11():195-204. PubMed ID: 63964
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study Group.
    Bernstein ID; Evans AE; Finklestein J; Klemperer M; Hittle R; Leikin S; Hammond GD
    Cancer Treat Rep; 1978 Aug; 62(8):1201-2. PubMed ID: 80272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer.
    Baker LH; Opipari MI; Wilson H; Bottomley R; Coltman CA
    Obstet Gynecol; 1978 Aug; 52(2):146-50. PubMed ID: 79991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinblastine (NSC-49842) and bleomycin (NSC-125066) therapy for disseminated testicular tumors.
    Spigel SC; Coltman CA
    Cancer Chemother Rep; 1974; 58(2):213-6. PubMed ID: 4133838
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma.
    Samuels ML; Barkley HT; Holoye PY; Rosenberg PJ; Smith TL
    Cancer Chemother Rep; 1975; 59(2 Pt 1):377-83. PubMed ID: 50124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
    De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
    Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
    Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
    Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bleomycin for malignant tumours of the genitals of the male (author's transl)].
    Rathert P; Terhorst B; Lutzeyer W
    Urologe A; 1974 Mar; 13(2):67-71. PubMed ID: 4134047
    [No Abstract]   [Full Text] [Related]  

  • 10. Bleomycin (NSC-125066) therapy of responsive solid tumors.
    Durkin WJ; Pugh RP; Jacobs E; Sadoff L; Pajak T; Bateman JR
    Oncology; 1976; 33(5-6):260-4. PubMed ID: 68454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of disseminated germinal tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D.
    Spigel SC; Stephens RL; Haas CD; Jones HS; Lehane D; Moon TE; Coltman CA
    Cancer Treat Rep; 1978 Jan; 62(1):129-30. PubMed ID: 75064
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiblastic chemotherapy and surgery in the treatment of cancer of the penis].
    Luciani L; Muraro GB; Menichelli E; Rizzo M
    Minerva Urol; 1977; 29(6):273-7. PubMed ID: 77473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)].
    Körner F; Lund S; Jonas U
    MMW Munch Med Wochenschr; 1975 Aug; 117(34):1345-8. PubMed ID: 52114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with bleomycin and some immunological implications.
    Barduagni A; Marolla A; Calabresi F; Terzoli E
    Prog Biochem Pharmacol; 1976; 11():185-94. PubMed ID: 63963
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cervical carcinoma with methotrexate, bleomycin and vincristine.
    Behnam K; Lewis GC; Lee JH; Looka MH
    Cancer Clin Trials; 1981; 4(1):75-9. PubMed ID: 6163568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies.
    Tormey DC; Bergevin P; Blom J; Petty W
    Cancer Chemother Rep; 1973; 57(4):413-8. PubMed ID: 4128422
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental chemotherapy in carcinoma of the cervix.
    Papadimitriou G; Razis D; Panopoulos C; Lappas C; Gnafakis N
    Int Surg; 1974 Sep; 59(9):472-5. PubMed ID: 4137657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.